Recent developments in the mechanism of anticancer agents based on electron transfer, reactive oxygen species and oxidative stress

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 7, 2011, Pages 658-668

  Kovacic, Peter ^a   Somanathan, Ratnasamy ^b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b TIJUANA INSTITUTE OF TECHNOLOGY   (Mexico)

Author keywords

Anticancer; Electron transfer; Oxidative stress; Reactive oxygen species

Indexed keywords

1,4 NAPHTHAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE; BORTEZOMIB; CAMPTOTHECIN; CISPLATIN; CRIBROSTATIN; CURCUMIN; CYTARABINE; CYTODYNIN DERIVATIVE; DAUNORUBICIN; DEHYDROASCORBIC ACID; DEOXYAMPHIMEDINE; DICOUMAROL; DNA TOPOISOMERASE INHIBITOR; ELLIPTICINE; FLAVONOID; GENISTEIN; HYDROXAMIC ACID; HYDROXYUREA; KUANONIAMINE; NORAMPHIDINE; OXYMATRINE; PYRIDOACRIDINE DERIVATIVE; PYRIMIDOTHIENOQUINOLINE DERIVATIVE; PYRROLOIMINOQUINONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SAPONIN DERIVATIVE; THYMOQUINONE; TOLUQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; DRUG MECHANISM; ELECTROCHEMISTRY; ELECTRON TRANSPORT; ENZYME INHIBITION; GENE EXPRESSION; GRANULOCYTE; HEAD AND NECK CARCINOMA; HUMAN; IONIZING RADIATION; LIPID PEROXIDATION; NONHUMAN; ONCOGENE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHAGOCYTOSIS; PHOTODYNAMIC THERAPY; RADIATION DOSE; SENESCENCE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 80051756769     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011796817691     Document Type: Article

References (62)

1. Kovacic, P.; Osuna Jr, D. A. Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr. Pharmaceut. Des., 2000, 6, 277-309.
2. Kovacic, P., Somanathan, R. Novel, unifying mechanism for aromatic primary-amines (therapeutics, carcinogens and toxins): electron transfer, reactive oxygen species, oxidative stress and metabolites. Med. Chem. Commun., 2011, 2, 106-112.
3. Kovacic, P.; Becvar, L. E. Mode of action of anti-infective agents: focus on oxidative stress and electron transfer. Curr. Pharmaceut. Des., 2000, 6, 143-167.
4. Kovacic, P.; Jacintho, J. D. Mechanism of carcinogenesis: focus on oxidative stress and electron transfer. Curr. Med. Chem., 2001, 8, 773-796.
5. Gutteridge, J. M. C.; Quinlan, G. J.; Kovacic, P. Phagomimetic action of antimicrobial agents. Free Rad. Res., 1998, 28, 1-14.
6. Kovacic, P. Unifying mechanism for anticancer agents involving electron transfer and oxidative stress. Clinical implications. Med. Hypotheses, 2007, 69, 510-516.
7. Manda, G.; Nechifor, M. T.; Neagu, T-M. Reactive oxygen species, cancer and anti-cancer therapies. Curr. Chem. Biol., 2009, 3, 342-366.
8. Tandon, V. R.; Sharma, S.; Mahajan, A.; Bardi, G. H. Oxidattive stress: a novel strategy in cancer treatment. JK SCIENCE, 2005, 7, 1-3.
9. Gulam, W.; Ahsan, H. Reactive oxygen species: role in the development of cancer and various chronic conditions. J. Carcinog., 2006, 5, 14.
10. Weinberg, F.; Chandel, N. S. Reactive oxygen species-dependent signaling regulates cancer. Cell Mol. Life Sci., 2009, 66, 3663-3673.
11. Kohchi, C.; Inagawa, H.; Nishizawa, T.; Soma, G-I. ROS and innate immunity. Anticanc. Res., 2009, 29, 817-821.
12. Tang, C.; Ang, B. T.; Pervaiz, S. Cancer stem cell: target for anticancer therapy. FASEB J., 2007, 21, 3777-3785.
13. Benhar, M.; Engelberg, D.; Levitzki, A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Reports, 2002, 3, 420-425.
14. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C. J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cellu. Biochem., 2004, 266, 37-56.
15. Renschler, M. F. The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer, 2004, 40, 1934-1940.
16. Fruehauf, J. P.; Meyskens F. L. Reactive oxygen species: a breath of life or death. Clin. Canc. Res., 2007, 23, 789-794.
17. Young, C. D.; Anderson, S. M. Rah, rah, ROS: metabolic changes by loss of adhesion. Breast Cancer Res., 2009, 11, 307.
18. Schumacker, P. T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Canc. Cell, 2006, 10, 175-176.
19. Lu, W.; Ogasawara, M. A.; Huang, P. Models of reactive oxygen species in cancer. Drug Discov. Today Dis. Models, 2007, 4, 67-73.
20. Ralph, S. J.; Rodriguez-Enrìquez, S.; Neuzil, J., Moreno-Sánchez, R. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol. Aspects Med., 2010, 31, 29-59.
21. Mantovani, G.; Maccio, A.; Madeddu, C.; Mura, L.; Massa, E.; Gramignano, G.; Lusso, M. R., Murgia, V.; Camboni, P.; Ferreli, L. Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J. Environ. Pathol. Toxicol. Oncol., 2003, 22, 17-28.
22. Pizzimenti, S.; Toaldo, C.; Pettazzoni, P.; Dianzani, M. U.; Barrera, G. The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancer, 2010, 2, 338-363.
23. Weaver, A. M. Regulation of cancer invasion by reactive oxygen species and Tks family scaffold proteins. Sci. Signal, 2009, 2, pe 56, DOI: 10.1126/scisignal.288pe56.
24. Neuzil, J.; Wang, X-F.; Dong, L-F.; Low, P.; Ralph, S. J. Molecular mechanism of 'miticon,-induced apoptosis in cancer cells epitomizes the multiple roles of reactive oxygen species and Bcl-2 family proteins. FEBS Lett., 2006, 580, 5125-5129.
25. Qutub, A. A.; Popel, A. S. Reactive oxygen species regulate hypoxia-inducible factor 1􀀄 differentially in cancer and ischemia. Mol. Cell. Biol., 2008, 28, 5106-5119.
26. Luanpitpong, S.; Talbott, S. J.; Rojanasakul, Y.; Nimmannit, U.; Pongrakhananon, V.; Wang, L.; Chanvorachote, P. Regulation of lung cancer cell migration and invasion by reactive oxygen species and Caveolin-1. J. Biol. Chem., 2010, 285, doi: 10.1074/jbc. M110.124958.
27. Ishikawa, K.; Takenaga, K.; Akimoto, M.; Koshikawa, N.; Yamaguchi, A.; Imanishi, H.; Nakada, K.; Honma, Y.; Hayashi, J-I. ROS-generating mitochondrial DNA mutations can regulate tumor cell matastasis. Cell Adh. Migr., 2009, 3, 11-13.
28. Mailloux, R. J.; Adjeitey, C. N-K.; Harper, M-E. Genipin-induced inhibition of uncoupling protein-2 sensitizes drug-resistant cancer cells to cytotoxic agents. Plos ONE, 2010, 5(10): e13289. doi10.1371/journal.pone.0013289.
29. Khaitan, D.; Dwarakanath, B. S. Endogenous and induced oxidative stress in multi-cellular tumor spheroids: implications for improving tumor therapy. Indian J. Biochem. Biophys., 2009, 46, 16-24.
30. Diehn, M.; Cho, R. W.; Lobo, N. A.; Kalisky, T.; Dorie, M. J.; Kulp, A. N.; Qian D.; Lam, J. S.; Ailles, L. E.; Wong, M.; Joshua, B.; Kaplan, M. J.; Wapnir, I.; Dirbas, F. M.; Solo, G.; Gargeroglio, C.; Paz, B.; Shen, J.; Lau, S. K.; Quake, S. R.; Brown, J. M.; Weissman, I. L.; Clarke, M. F. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature, 2009, 458, 780-783.
31. Kovacic, P.; Somanathan, R. Mechanism of conjugated imine and iminium species, including marine alkaloids: electron transfer, reactive oxygen species, therapeutic and toxicity. Curr. Bioact. Compds., 2010, 6, 46-59.
32. Adrian, T. E. Novel marine-derived anti-cancer agents. Curr. Pharmaceut. Des., 2007, 13, 3417-3426.
33. Kovacic, P.; Somanathan, R. Novel unifying mechanism for aromatic primary-amines (therapeutics, carcinogens and toxins): electron transfer, reactive oxygen species, oxidative stress and metabolites. Med. Chem. Commun., 2011, 2, 106-112.
34. Marshall, K. M.; Andjelic, C. D.; Tasdemir, D.; Concepción, Ireland, C. M.; Barrows, L. R. Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via production of reactive oxygen species. Mar. Drugs, 2009, 7, 196-209.
35. Zhang, Y.; Liu, H.; Jin, J.; Zhu, X.; Lu, L.; Jiang, H. The role of endogenous reactive oxygen species in oxymatrine-induced caspase-3-dependent apoptosis in human melanoma A375 cells. Anti-Cancer Drugs, 2010, 21, 494-501.
36. Shenoy, S.; Vasania, V. S.; Gopal, M. 8-Methyl-4-(3-diethylaminopropylamino) pyrimido [4',5';4,5] thieno (2,3-b) quinoline (MDPTQ), a quinoline derivative that causes ROS-mediated apoptosis in leukemia cell lines. Toxicol. Appl. Pharmacol., 2007, 222, 80-88.
37. Verma, R. P. Anti-cancer activities of 1,4-naphthaquinones: a QSAR study. Anticancer Agents Med. Chem., 2006, 6, 489-499.
38. Whibley, C. E.; McPhail, K. L.; Keyzers, R. A.; Maritz, M. F.; Leaner, V. D.; Birrer, M. J.; Davis-Coleman, M. T.; Hendricks, D. T. Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones. Mol. Cancer Ther., 2007, 6, 2535-2543.
39. Gali-Muhtasib, H.; Roessner, A.; Schneider-Stock, R. Thymoquinone: a promising anti-cancer drug from natural source. Int. J. Biochem. Cell Biol., 2006, 38, 1249-1253.
40. Hoyt, M. T.; Palchaudhuri, R. Cribrostatin 6 induces death in cancer cells through a reactive oxygen species (ROS)-mediated mechanism. Invst. New Drugs, doi: 10.1007/s10637-010-9390-x.
41. Li, P.; Goodwin, C.; Sang, Y.; Rossen, E. M.; Laterra, J.; Xia, S. Camptothecin and Fas receptor agonist synergistically induce medulloblastoma cell death: ROS-dependent mechanisms. Anticancer Drugs, 2009, 20, 770-708.
42. Kovacic, P. Anticancer quinones and quinolines: mode of action via electron transfer and oxidative stress. Redox Chemistry and Interfacial Behavior of Biological Molecules. Dryhurst, G; Niki, K. Eds. Plenum Press, New York, 1988, 295-307.
43. Yu, Y.; Wang, L-S.; Shen, S-M.; Xia, L.; Zhang, L.; Zhu, Y-S.; Chen, G-Q. Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells. J. Proteome Res., 2007, 6, 3808-3818.
44. Dvoranová, D.; Brezová, V.; Valko, M.; Staško, A. Photoinduced transformation of camptothecin in the presence of iron (III) ions. J. Phtochem. Photobiol. A: Chemistry, 2007, 185, 172-180.
45. Roopan, S. M.; Khan, F. R. N. Synthesis, antioxidant, hemolytic and cytotoxicity activity of AB ring core of mappicine. ARKIVOV, 2009, (XIII), 161-169.
46. Efferth, T.; Oesch, F. Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclins. Biochem. Pharmacol., 2004, 68, 3-10.
47. Chaturvedi, D.; Goswami, A.; Saikia, P. P.; Barua, N. C.; Rao, P. G. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents. Chem. Soc. Rev., 2010, 39, 435-454.
48. Kovacic, P. Hydroxamic acids (therapeutics and mechanism): chemistry, acyl nitroso, nitroxyl, reactive oxygen species, and cell signaling. J. Recept. Signal Transduct., 2011, 31, 10-19.
49. Kovacic, P. Hydroxurea (therapeutics and mechanism): metabolism, carbamoyl nitroso, nitroxyl, radicals, cell signaling and clinical applications. Med. Hypotheses, 2011, 76, 24-31.
50. Lin, C-L.; Lin, J-K. Curcumin: a potential cancer chemopreventive agent through suppressing NF-kB signaling. J. Cancer Mol., 2008, 4, 11-16.
51. Sarkar, F. H.; Wang, Z.; Padhye, S. Lesson learned from nature for the development of novel ant-cancer agents: implications of isoflavone, and their synthetic analogs. Curr. Pharm. Des., 2010, 16, 1801-1812.
52. Teyssot, M. L.; Jarrousse, A. S.; Manin, M.; Chevry, A.; Roche, S.; Norre, F.; Beaudoin, C.; Morel, L.; Boyer, D.; Mahiou, R.; Gautier, A. Metal-NHC complexes: a survey of anti-cancer properties. Dalton Trans., 2009, 6894-6902.
53. Davis, M. E.; Zhuo, C.; Shim, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nature Rev. Drug Discov., 2008, 7, 771-782.
54. Kovacic, P.; Somanathan, R. Biomechanisms of nanoparticles (toxicants, antioxidants and therapeutics); electron transfer and reactive oxygen species. J. Nanosci. Nanotech., 2010, 10, 7919-7930.
55. Amin, A.; Buratovich, M. The anti-cancer charm of flavonoids: a cup-of-tea will do! Recent Pat. Anticancer Drug Discov., 2007, 2, 109-117.
56. Du, J.; Daniels, D. H.; Asbury, C.; Venkataraman, S.; Liu, J.; Spitz, D. R. Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells. J. Biol. Chem., 2006, 281, 37416-37426.
57. Toohey, J. I. Dehydroascorbic acid as an anti-cancer agent. Cancer Lett., 2008, 263, 164-169.
58. Wang, Q.; Zheng, X-L.; Yang, L.; Shi, F.; Gao, L-B.; Zhong, Y-J.; Sun, H.; He, F.; Lin, Y.; Wang, X. Reactive oxygen speciesmediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J. Exp. Clin. Cancer Res., 2010, 29, 159.
59. Saw, C. L-L.; Wu, Q.; Kong, A-N. T. Anti-cancer and potential chemoprreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways. Chinese Medicine, 2010, 5, 37.
60. Fribley, A.; Zeng, Q.; Wang, C-Y. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma. Mol. Cell. Biol., 2004, 24, 9695-9704.
61. Zuluaga, M. F.; Lange, N. Combination of photodynamic therapy with ant-cancer agents. Curr. Med. Chem., 2008, 15, 1655-1573.
62. Bencokova, Z.; Balosso, J.; Foray, N. Radiobiological features of the anti-cancer strategies involving synchrotron X-rays. J. Synchrotron Radiat., 2007, 15, 74-85.